Optimizing Patient Outcomes in the Era of PCSK9 Inhibitor Therapeutics

transbgnla5

Date

Thursday, May 18, 2017
Registration & Dinner 6:30 pm to 7:00 pm
CME Symposium 7:00 pm to 9:00 pm

Location

Grand Ballroom BCD
Philadelphia Downtown Marriot
Register Today

 

Target Audience

Cardiologists, Lipidologists, and other healthcare professionals responsible for the diagnosis, treatment or management of patients with dyslipidemia.


Learning Objectives

  1. Review advances in LDL-C science and the role of LDL-C in CVD prevention
  2. Understand the current ACC/AHA/ESC/NLA guidelines for the management of patients with dyslipidemia.
  3. Analyze extended CVD Outcomes clinical trial data for PCSK9 inhibitor therapeutics.
  4. Apply newer scientific knowledge and data into personalized treatment plans for patients with statin intolerance, familial hypercholesterolemia, and dyslipidemia patients not at LDL-C goal.

Agenda

6:30 – 7:00 pm Registration and Dinner
7:00 – 7:10 pm Introduction and State of the Science: Dyslipidemia
7:10 – 7:25 pm Analyzing the Role of LDL-C in Atherosclerotic Disease and Guidelines Update
7:25 – 7:30 pm Interactive Expert Panel Discussion
7:30 – 7:50 pm Screening, Diagnosis and Current Management of Patients with FH
7:50 – 8:00 pm Interactive Expert Panel Discussion
8:00 – 8:20 pm CVD Outcomes Data for PCSK9 Inhibitor Therapeutics
8:20 – 8:30 pm Interactive Expert Panel Discussion
8:30 – 9:00 pm Lipid Clinic: Grand Rounds

 

Location

Philadelphia Downtown Marriott

Grand Ballroom BCD

1201 Market St.

Philadelphia, PA 19107


Registration Fees

This a complimentary CME symposium.


Accreditation Statement

 

In support of improving patient care, this activity has been planned and implemented by the National Lipid Association and AcademicCME. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is eligible for CDR credit.

This activity is endured and distributed through the Elsevier Office of Continuing Medical Education.


CE Inquiries/Special Needs

For all CE inquiries or special needs, please contact: admin@academiccme.com or 6106873300.


Financial Support

This activity has been supported by an independent educational grant from Amgen Inc.

 

Faculty

Christopher P. Cannon, MD

Professor of Medicine

Harvard Medical School

Executive Director of Cardiometabolic Trials

Baim Institute for Clinical Research

Senior Physician, Cardiovascular Division

Brigham and Women’s Hospital

Boston, Massachusetts

 

 

Christie M. Ballantyne, MD

Professor of Medicine

Baylor College of Medicine

Center for Cardiovascular Disease Prevention

Houston Methodist DeBakey Heart & Vascular Center

Baylor College of Medicine

Houston, Texas

 

Harold E. Bays, MD

Medical Director and President

Louisville Metabolic and Atherosclerosis Research Center

Louisville, Kentucky

 

G. Kees Hovingh, MD

Department of Vascular Medicine

Academic Medical Center

Amsterdam, Netherlands

 

James A. Underberg, MD

Clinical Assistant Professor of Medicine

NYU School of Medicine

NYU Center for Prevention of Cardiovascular Disease

Director Bellevue Hospital Lipid Clinic

President-Elect National Lipid Association

New York, New York